Methods of use and compositions of R(-) fluoxetine
Patent 5708035 Issued on January 13, 1998. Estimated Expiration Date: May 22, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/649, Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain514/651, Ether oxygen is part of the chain514/654The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only
A method and composition are disclosed utilizing the pure R(-) isomer of fluoxetine which is a potent antidepressant and appetite suppressant substantially free of adverse effects. In addition, a method and composition are disclosed utilizing the pure R(-) isomer of fluoxetine which is useful to treat migraine headaches, pain, in particular chronic pain, psychoactive substance abuse disorders and obsessive compulsive disorders.
Other References
Power-Smith, "Beneficial Sexual Side-effects from Fluoxetine," Brit. J. Psychiatry 164:249-250 (1994)
Saper et al., "Double-Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine," Headache 34:497-502 (1994)
Stevens et al., "Interaction of the Enantiomers of Fluoxetine and Norfluoxetine with Human Liver Cytochromes P450," J. Pharmacology & Experimental Therapeutics 226(7):964-971 (1993)
Bergstrom et al., "Quantification and Mechanism of the Fluoxetine and Tricyclic Antidepressant Interaction," Clin. Pharmacol. Ther. 51:239-248 (1992)
Adly et al., "Fluoxetine Prophylaxis of Migraine," Headache 32:101-104 (1992)
Caccia et al., "Influence of Dose and Route of Administration on the Kinetics of Fluoxetine and Its Metabolite Norfluoxetine in the Rat", Psychopharmacology 100:509-514 (1990)
Physicians Desk Reference, pp. 905-908, 44th Ed., Medical Economics Data Production Co., N.J. (1990)
Teicher et al., "Emergence of Intense Suicidal Preoccupation During Fluoxetine Treatment", Am. J. Psychiatry 147(2):207-210 (1990)
Wong et al., "Fluoxetine and Its Two Enantiomers as Selective Serotonin Uptake Inhibitors", Acta Pharm. Nord. 2(3):171-180 (1990)
Corey and Reichard, "Enantioselective and Practical Synthesis of R-and S-Fluoxetines", Tetrahedron Lett. 30(39):5207-5210 (1989)
Coutts and Baker, "Implications of Chirality and Geometric Isomerism in Some Psychoactive Drugs and Their Metabolites", Chirality 1:99-120 (1989)
Coutts and Baker, "Metabolic Implications of Chiral Centres in Psychotropic Drugs", Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13:405-417 (1989)
Jamali et al., "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls", J. Pharm. Sci. 78(9):695-715 (1989)
Gao and Sharpless, "Asymmetric Synthesis of Both Enantiomers of Tomoxetine and Fluoxetine. Selective Reduction of 2,3-Epoxycinnamyl Alcohol with Red-Al", J. Org. Chem. 53(17):4081-4084 (1988)
Kim and Wurtman, "Selective Effects of CGS 10686B, d1-Fenfluramine or Fluoxetine on Nutrient Selection", Physiology & Behavior 42:319-322 (1988)
Robertson et al., "Absolute Configurations and Pharmacological Activities of the Optical Isomers of Fluoxetine, a Selective Serotonin-Uptake Inhibitor", J. Med. Chem. 31:1412-1417 (1988)
Wong et al., "Suppression of Food Intake in Rats by Fluoxetine: Comparison of Enantiomers and Effects of Serotonin Antagonists", Pharmacology Biochemistry & Behavior 31:475-479 (1988)
Benfield et al., "Fluoxetine: A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Depressive Illness", Drugs 32:481-508 (1986)
Fuller and Snoddy, "Fluoxetine Enantiomers as Antagonists of p-Chloroamphetamine Effects in Rats", Pharmacology Biochemistry & Behavior 24:281-284 (1986)
Scrips' New Product Review, No. 7, pp. 13-14 (1986)
Wong et al., "Inhibition of Serotonin Uptake by Optical Isomers of Fluoxetine", Drug Development Research 6:397-403 (1985)
Bremner, "Fluoxetine in Depressed Patients: A Comparison with Imipramine", J. Clin. Psychiatry 45(10):414-420 (1984
May 22, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
